Chirocaine is a drug owned by Purdue Pharma Lp. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Oct 13, 2014. Details of Chirocaine's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5708011 | Use of levobupivacaine in a patient having depressed myocardial contractility |
Oct, 2014
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Chirocaine is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Chirocaine's family patents as well as insights into ongoing legal events on those patents.
Chirocaine's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Chirocaine's generic launch date based on the expiry of its last outstanding patent is estimated to be Oct 13, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Chirocaine Generics:
There are no approved generic versions for Chirocaine as of now.
About Chirocaine
Chirocaine is a drug owned by Purdue Pharma Lp. It is used for local anesthesia and pain management. Chirocaine uses Levobupivacaine Hydrochloride as an active ingredient. Chirocaine was launched by Purdue Pharma Lp in 1999.
Approval Date:
Chirocaine was approved by FDA for market use on 05 August, 1999.
Active Ingredient:
Chirocaine uses Levobupivacaine Hydrochloride as the active ingredient. Check out other Drugs and Companies using Levobupivacaine Hydrochloride ingredient
Treatment:
Chirocaine is used for local anesthesia and pain management.
Dosage:
Chirocaine is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 2.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE | Discontinued | INJECTION |
| EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE | Discontinued | INJECTION |
| EQ 7.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE | Discontinued | INJECTION |